The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $58.96

Today's change+0.44 +0.75%
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $58.96

Today's change+0.44 +0.75%
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.

Merck & Co Inc Hits New 20-day High

Merck & Co Inc closed up Friday by (U.S.)$0.44 or 0.75% to (U.S.)$58.96 and setting a new 20-day high. Over the last five days, shares have gained 2.70% and 3.82% year to date. Shares have underperformed the S&P 500 by 5.06% during the last year.

Key company metrics

  • Open(U.S.) $59.00
  • Previous close(U.S.) $58.52
  • High(U.S.) $59.33
  • Low(U.S.) $58.70
  • Bid / Ask-- / --
  • YTD % change+3.82%
  • Volume8,752,452
  • Average volume (10-day)9,529,089
  • Average volume (1-month)8,661,165
  • Average volume (3-month)9,419,810
  • 52-week range(U.S.) $52.49 to (U.S.) $63.62
  • Beta0.44
  • Trailing P/E17.25×
  • P/E 1 year forward16.78×
  • Forward PEG2.46×
  • Indicated annual dividend(U.S.) $1.80
  • Dividend yield3.05%
  • Trailing EPS(U.S.) $3.42
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+24.39%

Based on its net profit margin of 24.39%, Merck & Co Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue9,42510,48210,55710,934
Total other revenue--------
Total revenue9,42510,48210,55710,934
Gross profit5,9616,8386,4216,212
Total cost of revenue3,4643,6444,1364,722
Total operating expense7,9899,3069,2339,693
Selling / general / administrative2,3382,7872,7972,897
Research & development1,7352,0811,4841,621
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)452794816453
Other operating expenses, total--------
Operating income1,4361,1761,3241,241
Interest income (expense), net non-operating-164-165-191-188
Gain (loss) on sale of assets--------
Other--------
Income before tax1,38111,8111,4901,891
Income after tax9587,3278422,033
Income tax, total4234,484648-142
Net income9537,3168952,004
Total adjustments to net income--------
Net income before extra. items9537,3168952,004
Minority interest-5-1153-29
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9537,3168952,004
Inc. avail. to common incl. extra. items9537,3168952,004
Diluted net income9537,3168952,004
Dilution adjustment----00
Diluted weighted average shares2,8652,8862,9112,949
Diluted EPS excluding extraordinary itemsvalue per share0.332.540.310.68
Dividends per sharevalue per share0.450.440.440.44
Diluted normalized EPSvalue per share0.444.410.470.78